Skip to content

Clinical trials

Phase 1/2 Arthritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis Phase: Phase 1/2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20091
20151
20181
20191
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Withdrawn2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARKAY Therapeutics1
Hope Biosciences LLC1
Indiana University1
Iowa State University1
Oklahoma Medical Research Foundation1
Targeted Genetics Corporation1
TricelX Inc.1
UCB Pharma1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis9
Arthritis, Rheumatoid3
Lupus Erythematosus, Systemic2
Arthritis, Juvenile1
Arthritis, Psoriatic1
Dermatomyositis1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Frailty1
Hypertension1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.